Adam Hull focuses his practice on representing venture capital and private equity funds in their investment activities across multiple industry verticals, including biotech/life sciences, consumer products, innovative technology, Web3, fintech, healthcare, and real estate.

Adam also regularly works with emerging companies throughout their lifecycle, with particular emphasis on later-stage venture capital and growth equity financings, strategic corporate relationships, securities regulation, and complex mergers and acquisitions.